Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: A 12-Gene Blood-Based Signature for Detecting Metastatic Bladder Cancer
A terminated clinical trial evaluated a 12-gene blood-based signature for detecting metastatic bladder cancer.
-
CLINICAL_TRIALS trial_result · 2015-02-04Clinical Trial Update: BCG Modulation of the recMAGE-A3 + AS15 ASCI Response in the Treatment of Non Muscle Invasive Bladder Cancer (NMIBC) Patients [Phase 1]
Phase 1 clinical trial evaluating modulation of the recMAGE-A3 ASCI vaccine with AS15 adjuvant using BCG in non-muscle invasive bladder canc…
-
CLINICAL_TRIALS research · 2015-02-04Clinical Trial Update: Clinical Trial Using Bipolar Technology for Transurethral Resection of Bladder Tumor [Phase 3]
Phase 3 clinical trial evaluating bipolar technology for transurethral resection of bladder tumors (TURBT) conducted by the Chinese Universi…
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Detection and Clinical Significance of Circulating Cancer Cells in Patient Undergoing Radical Cystectomy
This completed trial evaluated the detection and clinical significance of circulating tumor cells in patients undergoing radical cystectomy …
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Open Versus Laparoscopic Radical Cystectomy [Phase 2]
This Phase 2 clinical trial compares open versus laparoscopic radical cystectomy for bladder cancer; the current status of the study is unkn…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-01-21Clinical Trial Update: Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanced Transitional Cell Cancer of the Bladder [Phase 2]
This document reports the results of a Phase 2 trial evaluating the combination of paclitaxel, carboplatin, and gemcitabine in patients with…
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy [Phase 1]
This Phase 1 trial evaluating neoadjuvant intravesical vaccine therapy for bladder cancer patients undergoing cystectomy has been terminated…
-
CLINICAL_TRIALS trial_result · 2014-12-17Clinical Trial Update: Efficacy and Safety of Aprotinin on Transfusion Requirements in Patients Undergoing Radical or Total Cystectomy [Phase 3]
A Phase 3 trial evaluating whether aprotinin reduces transfusion needs in patients undergoing radical or total cystectomy was terminated, wi…
-
CLINICAL_TRIALS trial_result · 2014-12-15Clinical Trial Update: A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment [Phase 1, Phase 2]
Phase 1/2 study evaluating belinostat in combination with carboplatin and/or paclitaxel in relapsed ovarian cancer; results were posted in 2…
-
CLINICAL_TRIALS trial_result · 2014-12-12Clinical Trial Update: Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography [EARLY_Phase 1]
Early-phase (Phase 1) clinical trial evaluating the copper-64 radiotracer 64Cu-DOTA-AE105 for diagnosing aggressive cancers with PET; the st…
-
CLINICAL_TRIALS trial_result · 2014-12-10Clinical Trial Update: Incontinent Urinary Diversion Using an Autologous Neo-Urinary Conduit [Phase 1]
A completed Phase 1 trial assessing an autologous neo-urinary conduit for incontinent urinary diversion in bladder cancer patients.
-
CLINICAL_TRIALS trial_result · 2014-11-13Clinical Trial Update: Trial of Maintenance SUO11248 Versus Placebo Post Chemotherapy for Patients With Advanced Urothelial Carcinoma [Phase 2]
A Phase 2 trial comparing maintenance SUO11248 versus placebo after chemotherapy in patients with advanced urothelial carcinoma (bladder can…
-
FDA approval · 2014-11-05FDA Approved: DOXORUBICIN HYDROCHLORIDE — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for doxorubicin hydrochloride (Fresenius Kabi USA, LLC) under anANDA to support its generic product.
-
CLINICAL_TRIALS trial_result · 2014-10-27Clinical Trial Update: Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer [Phase 2]
A Phase 2 trial evaluating gemcitabine and cisplatin with or without cetuximab in urothelial cancer (bladder cancer); results were posted in…
-
CLINICAL_TRIALS withdrawal · 2014-10-07Clinical Trial Update: Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer [Phase 3]
A Phase 3 trial comparing hyperthermia with mitomycin C to Bacillus Calmette-Guérin (BCG) immunotherapy for superficial bladder cancer was t…
-
CLINICAL_TRIALS trial_result · 2014-10-03Clinical Trial Update: VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium [Phase 2]
A Phase 2 trial evaluating VEGF Trap (aflibercept) in patients with recurrent, locally advanced, or metastatic urothelial cancers has comple…
-
CLINICAL_TRIALS trial_result · 2014-10-02Clinical Trial Update: Sorafenib and Radiotherapy in the Treatment of Invasive Bladder Cancer With Conservative Intent [Phase 1]
A Phase 1 trial assessing the combination of sorafenib with radiotherapy for invasive bladder cancer treated with bladder-sparing intent; th…
-
CLINICAL_TRIALS withdrawal · 2014-10-02Clinical Trial Update: MRI and Bladder Cancer Chemotherapy
A clinical trial investigating MRI-guided techniques with chemotherapy for invasive bladder cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-09-19Clinical Trial Update: Trial of Combination ABI-007, Carboplatin, and Gemcitabine for First Line Treatment of Advanced Urothelial Cancer [Phase 2]
Phase 2 trial of ABI-007 (nab-paclitaxel) combined with carboplatin and gemcitabine as first-line therapy for advanced urothelial cancer; th…
-
CLINICAL_TRIALS trial_result · 2014-09-18Clinical Trial Update: Clinical Trial Of Neoadjuvant Chemotherapy (NAC)In Upper Tract Urothelial Carcinoma (UTUC) [Phase 2]
A Phase 2 neoadjuvant chemotherapy trial in upper tract urothelial carcinoma (and bladder cancer) was terminated, with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Radical Cystectomy, Nutrition and Convalescence [NA]
A completed clinical trial conducted by Rigshospitalet in Denmark evaluated nutrition and convalescence after radical cystectomy for bladder…
-
CLINICAL_TRIALS trial_result · 2014-08-25Clinical Trial Update: Effectiveness of Hexaminolevulinate (Hexvix) in the Diagnosis and Treatment of Patients With Non-invasive Bladder Cancer
Clinical trial results update on the effectiveness of Hexaminolevulinate (Hexvix) for diagnosing and treating non-muscle invasive bladder ca…
-
CLINICAL_TRIALS research · 2014-08-04Clinical Trial Update: Compare the Quality of Life Between Patients With Conduit Diversions or Orthotopic Neobladders
This clinical trial update compares quality of life in bladder cancer patients undergoing conduit diversions versus orthotopic neobladders; …
-
CLINICAL_TRIALS trial_result · 2014-07-31Clinical Trial Update: URO-BCG-4 : Bladder Tumors Immunotherapy
This is a completed clinical trial update for URO-BCG-4 investigating bladder tumor immunotherapy with intravesical Bacillus Calmette-Guérin…
-
CLINICAL_TRIALS withdrawal · 2014-07-29Clinical Trial Update: Imaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney Cancer [NA]
A clinical trial evaluating imaging during surgery to diagnose prostate, bladder, or kidney cancer has been withdrawn.